Outlook Therapeutics
OTLK
#8584
Rank
A$0.18 B
Marketcap
$7.90
Share price
-2.84%
Change (1 day)
-39.75%
Change (1 year)

Earnings for Outlook Therapeutics (OTLK)

Earnings in 2024 (TTM): -A$0.15 Billion

According to Outlook Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$79.3 Million, an increase over its 2022 earnings that were of -A$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Outlook Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.15 Billion83.68%
2023 -A$79.3 Million-26.7%
2022 -A$0.11 Billion32.13%
2021 -A$81.88 Million46.21%
2020 -A$56 Million-18.82%
2019 -A$68.99 Million16.62%
2018 -A$59.15 Million57.88%
2017 -A$37.47 Million-56.17%
2016 -A$85.48 Million-9.26%
2015 -A$94.2 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.18 Billion 21.71% Jersey
-A$0.43 Billion 190.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$21.54 Million-85.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.12 Billion-22.31%๐Ÿ‡ฌ๐Ÿ‡ง UK